Internal Medicine, Pulmonary Disease · Winston Salem, NC
NPI
1538141767
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3001 Lyndhurst Ave
Winston Salem, NC, 27103
Phone (336) 765-0383
Groups this clinician bills Medicare through
Medicare paid, 2024
$106K
2,591 services
Medicare patients, 2024
684
Average age 75
Drug cost, 2024
$2.3M
4,060 prescriptions
Company payments, 2025
$2,453
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas R Hinson Jr. was code 99214 (office e&m - established), 546 times for 448 patients. In total Thomas R Hinson Jr. billed 2,591 services in 34 codes, and Medicare paid $106K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 546 | 448 | $87.20 | $48K |
| 94010 Pulmonary Function Testing | Office | 314 | 310 | $19.08 | $5,991 |
| 94729 Pulmonary Function Testing | Office | 186 | 185 | $39.79 | $7,401 |
| 71046 X-ray - Chest | Office | 136 | 128 | $16.40 | $2,230 |
| 99213 Office E&M - Established | Office | 93 | 90 | $57.44 | $5,342 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 83 | 80 | $12.60 | $1,046 |
| 99204 Office E&M - New | Office | 83 | 83 | $120.88 | $10K |
| 99215 Office E&M - Established | Office | 68 | 65 | $123.08 | $8,370 |
| 99406 Behavioral Health Services | Office | 66 | 62 | $14.11 | $932 |
| 94618 Pulmonary Function Testing | Office | 63 | 63 | $24.92 | $1,570 |
| 94664 E&M - Miscellaneous | Office | 63 | 62 | $12.47 | $785 |
| 99457 E&M - Miscellaneous | Office | 52 | 46 | $35.17 | $1,829 |
| 99205 Office E&M - New | Office | 46 | 46 | $159.75 | $7,348 |
| G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 33 | 33 | $26.01 | $858 |
| 94727 Pulmonary Function Testing | Office | 24 | 24 | $33.81 | $812 |
By year: 2022 $122K for 2,393 services; 2023 $110K for 2,141 services; 2024 $106K for 2,591 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87502 Infectious Agent Detection by DNA/RNA | 12 | 12 | $93.88 | $1,127 |
| 87635 COVID Specific | 11 | 11 | $50.28 | $553 |
Medicare prescription drug claims, 2024
In 2024, the drug Thomas R Hinson Jr. prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 721 prescriptions and refills. In total Thomas R Hinson Jr. wrote 4,060 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 721 | 887 | 161 | $567K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 381 | 444 | 145 | $10K |
| Azithromycin Generic | 312 | 373 | 89 | $3,919 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 261 | 299 | 60 | $188K |
| Prednisone Generic | 257 | 286 | 135 | $928 |
| Breo Ellipta Fluticasone/Vilanterol | 215 | 271 | 55 | $107K |
| Montelukast Sodium Generic | 193 | 388 | 59 | $1,862 |
| Spiriva Respimat Tiotropium Bromide | 157 | 171 | 44 | $88K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 147 | 157 | 30 | $72K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 137 | 177 | 31 | $84K |
| Levofloxacin Generic | 125 | 133 | 105 | $660 |
| Symbicort Budesonide/Formoterol Fumarate | 123 | 186 | 37 | $41K |
| Cefuroxime Cefuroxime Axetil | 103 | 103 | 65 | $1,021 |
| Ventolin Hfa Albuterol Sulfate | 90 | 106 | 42 | $6,615 |
| Incruse Ellipta Umeclidinium Bromide | 49 | 49 | 14 | $17K |
Brand drugs: 2,454 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas R Hinson Jr. $2,453 ($2,453 in general payments such as food, travel and fees) from 23 companies. The largest payer was Verona Pharma, Inc. with $351.
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. VRNA | 18 | $351 |
| GlaxoSmithKline, LLC. GSK | 21 | $343 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $221 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $188 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $186 |
| Insmed, Inc. INSM | 13 | $164 |
| Genzyme Corporation SNY | 7 | $158 |
| United Therapeutics Corporation UTHR | 7 | $149 |
| Grifols USA, LLC | 6 | $130 |
| Harmony Biosciences LLC HRMY | 4 | $101 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.